A prospective study involving adolescents with severe acne shows that three months of isotretinoin does not impair cognitive function, though some mood-related symptoms tend to increase, highlighting the importance of psychiatric monitoring during treatment.
A new prospective study in adolescents with severe acne found no evidence that three months of isotretinoin harmed memory, learning or other measured cognitive skills, even as some mood-related symptoms worsened during treatment. Researchers reported that the drug sharply improved acne severity, but scores linked to depression, anxiety and related internalising symptoms rose in parts of the analysis, reinforcing the need for psychiatric monitoring in young patients.
The single-centre study followed 78 patients aged 13 to 18 years, most with nodulocystic or papulopustular acne judged to be severe or very severe. Before and after treatment, participants underwent psychiatric interviews and neuropsychological testing covering interference control, memory and learning. Of the original group, 31 completed the three-month follow-up. The authors reported that overall cognitive performance did not decline, and some measures of resistance to distraction appeared to improve, although that result did not remain significant after correction for multiple comparisons.
The psychiatric picture was more mixed. In the imputed analysis, scores for social phobia, panic disorder and major depressive disorder increased during treatment. Among those who completed the study, the rise in depressive symptoms was weaker and did not hold up after statistical adjustment. Importantly, the researchers said the changes were modest shifts in symptom scores rather than new diagnoses. No participant developed a fresh psychiatric disorder on structured interview, reported suicidal thoughts or self-harm, or needed urgent mental-health intervention.
The study also found no clear link between psychiatric or cognitive outcomes and inflammatory markers such as the neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio. Still, the researchers cautioned that the work had clear limits: it had no control group, excluded adolescents with current psychopathology and lost many participants to follow-up. Previous research has been broadly consistent with the idea that isotretinoin does not worsen cognition and may even improve some measures as acne clears, while psychiatric findings across studies remain mixed. For clinicians, the practical message is straightforward: isotretinoin remains effective for difficult acne, but mood should be watched closely, and parents and teenagers should be told to report changes early.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
